Benzinga - by Avi Kapoor, Benzinga Staff Writer.
U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.
Shares of NIO Inc. (NYSE: NIO) rose during Tuesday’s session following upbeat quarterly results.
NIO reported fourth-quarter revenue of 17.10 billion yuan ($2.41 billion), up by 6.5% year-over-year and down by 10.3% from the previous quarter. Analysts, on average, estimated revenue of $2.29 billion for the quarter. Excluding share-based compensation expenses, the company reported an adjusted loss of (2.81) yuan or ($0.39) compared to (3.07) yuan in the year-ago quarter and (2.28) yuan in the third quarter of 2023. Analysts had called for a loss of $(0.51) per share.
NIO shares gained 3.6% to $5.52 on Tuesday.
Here are some other big stocks recording gains in today’s session.
- Apogee Therapeutics, Inc. (NASDAQ: APGE) shares gained 41.6% to $59.10 after the company announced interim results from its Phase 1 healthy volunteer trial for APG777. Also, the company reported FY23 financial results.
- Dave Inc. (NASDAQ: DAVE) surged 39.8% to $30.62 after the company reported a year-over-year increase in fourth-quarter revenue results.
- AeroVironment, Inc. (NASDAQ: AVAV) shares climbed 24.8% to $163.05 after the company reported better-than-expected results for its fourth quarter. The company said it sees FY24 adjusted earnings of $2.69 to $2.83 per share on revenue of $700 million to $710 million.
- Paymentus Holdings, Inc. (NYSE: PAY) rose 20.3% to $19.67 after the company reported better-than-expected fourth quarter financial results.
- 3D Systems Corporation (NYSE: DDD) climbed 14.7% to $4.7150. 3D Systems announced additional partial repurchase of convertible senior notes.
- Fresenius Medical Care AG (NYSE: FMS) rose 12.2% to $20.95. Fresenius Medical Care achieved next milestone in portfolio optimization program, announcing sale of dialysis clinics in Brazil, Colombia, Chile, Ecuador.
- Krystal Biotech, Inc. (NASDAQ: KRYS) gained 11.6% to $178.44.
- New York Community Bancorp, Inc. (NASDAQ: NYCB) climbed 11.3% to $3.0411 after falling 23% on Monday. New York Community Bancorp last week announced that it identified material weaknesses in its internal controls and replaced its CEO.
- Spyre Therapeutics, Inc. (NASDAQ: SYRE) gained 11.3% to $38.92. Spyre Therapeutics recently reported a year-over-year increase in fourth-quarter EPS results.
- The RealReal, Inc. (NASDAQ: REAL) rose 10.7% to $3.5450.
- V2X, Inc. (NYSE: VVX) gained 10.4% to $42.66 after the company reported better-than-expected fourth-quarter results and provided upbeat FY24 guidance.
- Scholar Rock Holding Corporation (NASDAQ: SRRK) rose 10.3% to $16.94.
- Riskified Ltd. (NYSE: RSKD) gained 8.8% to $ 4.97 after the company reported better-than-expected fourth-quarter EPS and revenue but issued guidance below estimates.
- DaVita Inc. (NYSE: DVA) rose 7.4% to $135.14. DaVita entered into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador.
- Constellation Energy Corporation (NASDAQ: CEG) gained 4.9% to $184.63. On Monday, UBS maintained a Buy rating on the stock and raised its price target from $151 to $201.
- Harley-Davidson, Inc. (NYSE: HOG) rose 4% to $38.14. DA Davidson analyst Brandon Rolle reiterated Harley-Davidson with a Buy and maintained a $42 price target.
Now Read This: Bitcoin Surpasses $65,000; Pepe Emerges As Top Gainer
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.